/MDDVF
MDDVF Stock - Medical Developments International Limited
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.30+0.00%
+$0.00 (+0.00%) • Dec 19
50
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.13
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.61
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.33
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MDDVF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.30 – $0.31
TARGET (TP)$0.35
STOP LOSS$0.28
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.49
52W High$0.51
52W Low$0.25
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $39.06M | $33.15M | $32.34M | $21.94M | $25.27M |
| Gross Profit | $29.43M | $24.37M | $-2,516,000 | $-3,060,000 | $16.67M |
| Gross Margin | 75.3% | 73.5% | -7.8% | -13.9% | 66.0% |
| Operating Income | $3.07M | $-11,039,000 | $-14,427,000 | $-15,695,000 | $-5,239,000 |
| Net Income | $94,000 | $-40,992,000 | $-5,609,000 | $-12,407,000 | $-12,565,000 |
| Net Margin | 0.2% | -123.7% | -17.3% | -56.5% | -49.7% |
| EPS | $0.00 | $-0.47 | $-0.07 | $-0.17 | $-0.18 |
Company Overview
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease; Penthrox, a trauma and emergency pain relief product; and medical devices, such as CPR face shield key rings, CPR masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, OXI port carry and hand bags, oxygen resuscitation kits, oxygen therapy masks, and resuscitators. The company was incorporated in 2003 and is headquartered in Scoresby, Australia.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
MDDVFBeat Rate
50%
Last 4 quarters
Avg Surprise
+141.1%
EPS vs Estimate
Beats / Misses
2/2
Last 12 quarters
Latest EPS
$0.00
Q1 2025
EPS Surprise History
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Q1 24
-216.9%
$-0.08vs$-0.03
Q3 24
-67.1%
$-0.23vs$-0.14
Q1 25
+115.0%
$0.00vs$-0.01
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 18, 2026 | — | — | — | — |
Q1 2025 | Feb 26, 2025 | — | — | — | — |
Q1 2025 | Feb 19, 2025 | $-0.01 | $0.00 | +115.0% | ✓ BEAT |
Q3 2024 | Aug 25, 2024 | $-0.14 | $-0.23 | -67.1% | ✗ MISS |
Q2 2024 | Apr 28, 2024 | — | — | — | — |
Q1 2024 | Feb 28, 2024 | $-0.03 | $-0.08 | -216.9% | ✗ MISS |
Q4 2023 | Dec 30, 2023 | — | $-0.08 | — | — |
Q3 2023 | Aug 30, 2023 | — | $-0.07 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.06 | — | — |
Q1 2023 | Feb 23, 2023 | — | $0.02 | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.02 | — | — |
Q3 2022 | Aug 3, 2022 | — | — | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.05 | — | — |
Q1 2022 | Feb 24, 2022 | — | $-0.07 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.07 | — | — |
Q3 2021 | Aug 24, 2021 | — | $-0.04 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.12 | — | — |
Q1 2021 | Feb 25, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.01 | — | — |
Q3 2020 | Aug 20, 2020 | $0.01 | $0.07 | +733.3% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about MDDVF
What is MDDVF's current stock price?
Medical Developments International Limited (MDDVF) is currently trading at $0.30 per share. The stock has moved +0.00% today.
What is the analyst price target for MDDVF?
No analyst price targets are currently available for this stock.
What sector is Medical Developments International Limited in?
Medical Developments International Limited operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is MDDVF's market cap?
Medical Developments International Limited has a market capitalization of $0.03 billion, making it a small-cap company.
Does MDDVF pay dividends?
No, Medical Developments International Limited does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCANSF
Atlas Energy Corp.
$0.12
Mkt Cap: $0.0B
CBSTF
The Cannabist Company Holdings Inc.
$0.07
Mkt Cap: $0.0B
DSOL
Drug Free Solution, Inc.
$0.00
Mkt Cap: $0.0B
EOFBF
Ecofibre Limited
$0.00
Mkt Cap: $0.0B
GHBWF
Glass House Brands Inc.
$0.32
Mkt Cap: $0.0B
ITHUF
iAnthus Capital Holdings, Inc.
$0.01
Mkt Cap: $0.0B
LEEEF
Leef Brands Inc.
$0.18
Mkt Cap: $0.0B
NVYTF
Novacyt S.A.
$0.51
Mkt Cap: $0.0B
SEOVF
Sernova Corp.
$0.09
Mkt Cap: $0.0B
WOWU
WOWI, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to MDDVF for comparison